Animal biotechnology is the use of modern molecular and cellular tools to alter the genetic makeup, reproduction, or cell biology of animals for purposes ranging from food production to medicine. It encompasses techniques like gene editing, cloning, transgenesis, and cell culture, and its applications now stretch across agriculture, biomedicine, conservation, and environmental science. The field has accelerated dramatically since the arrival of precision gene-editing tools, but its roots go back decades to early work in artificial insemination, embryo transfer, and the first transgenic mice of the 1980s.
The Core Toolkit
Animal biotechnology relies on a handful of foundational techniques, each with different strengths and limitations. Understanding how they differ helps make sense of why certain applications have moved faster than others.
The oldest approach to creating genetically modified animals is pronuclear microinjection, where copies of a foreign gene are physically injected into a fertilized egg. This method was first used in rabbits, pigs, and sheep during the 1980s. Its chief drawback is that the foreign DNA lands in a random spot in the host genome, which can disrupt existing genes and produce unpredictable expression. The success rate is low: out of every hundred injected embryos, typically only one to four produce a transgenic animal, and in cattle the rate is even worse.1Journal of Genetic Engineering and Biotechnology. A review of transgenic animal techniques and their applications
Somatic cell nuclear transfer, commonly called cloning, takes the nucleus from an adult body cell and places it into an egg cell whose own nucleus has been removed. This is the technique behind Dolly the sheep. While cloning can produce genetically identical copies of high-value animals, developmental problems are common and have been linked to incomplete reprogramming of the donor nucleus during the process.2PubMed Central. Cloning animals by somatic cell nuclear transfer–biological factors
The real game-changer arrived with site-specific nucleases, particularly CRISPR-Cas9. Earlier nuclease tools had already made precision editing possible, but CRISPR dramatically reduced the time and cost involved while allowing more extensive modifications.3PubMed. CRISPR in Animals and Animal Models These tools can be used on their own to knock out a gene with relatively high efficiency, or paired with a DNA template to insert specific changes, though the insertion step remains less efficient.4Journal of Equine Veterinary Science. Genome Editing in Large Animals Alongside these genetic techniques, a broader suite of assisted reproductive technologies like artificial insemination, embryo transfer, and in vitro fertilization supports animal breeding programs and makes it possible to propagate genetically improved animals at scale.5Academic Press. Role of biotechnology on animal breeding and genetic improvement
Building Disease-Resistant Livestock
One of the most promising agricultural uses of gene editing is creating livestock that can resist devastating infections. Porcine reproductive and respiratory syndrome (PRRS) is one of the most costly diseases in the global pig industry, causing respiratory failure, reproductive losses, and widespread death in herds. The virus uses a protein on pig cells called CD163 as its entry point. Researchers used CRISPR-Cas9 to modify the CD163 gene in pigs, and the results were striking: when exposed to a highly pathogenic strain of the virus, gene-edited pigs showed dramatically lower viral loads and survived, while all of the unedited control pigs died.6PubMed Central. Generation of Pigs Resistant to Highly Pathogenic-Porcine Reproductive and Respiratory Syndrome Virus through Gene Editing of CD163 A separate study went further, knocking out CD163 entirely and finding that those pigs were completely resistant to the virus, with no detectable infection, fever, or clinical signs, and no loss of the gene’s normal biological function.7PubMed. CD163 knockout pigs are fully resistant to highly pathogenic porcine reproductive and respiratory syndrome virus
This kind of work is significant not just because it protects individual animals but because widespread disease resistance in herds could reduce antibiotic use, lower mortality, and stabilize food supply chains. PRRS alone costs the U.S. pork industry hundreds of millions of dollars annually, so a genetic solution would have enormous economic consequences.
More Muscle, More Heat Tolerance
Beyond disease, gene editing is being applied to traits that directly affect meat production and animal welfare in changing climates. Myostatin is a protein that acts as a natural brake on muscle growth. In some cattle breeds, natural mutations in the myostatin gene produce a “double-muscled” appearance with significantly more lean mass. Researchers have now replicated and refined these mutations using gene editing in multiple livestock species, producing animals with higher growth rates and increased muscle mass. Studies across species generally support a favorable effect on both the quantity and quality of the resulting meat.8PubMed. When Less Is More: Targeting the Myostatin Gene in Livestock for Augmenting Meat Production Interestingly, myostatin knockout also appears to shift liver metabolism in cattle, promoting bile acid synthesis, an effect whose long-term implications for animal health are still being studied.9PubMed Central. Myostatin Knockout Regulates Bile Acid Metabolism by Promoting Bile Acid Synthesis in Cattle
Climate adaptation is another active frontier. As temperatures rise, heat stress reduces productivity and threatens the welfare of cattle in tropical and subtropical regions. Some tropical breeds naturally carry a mutation in the prolactin receptor gene (PRLR) that gives them a short, sleek coat, helping them shed heat more effectively. Using CRISPR-Cas9, researchers introduced this “slick” mutation into heat-sensitive breeds like Angus and Jersey cattle. The gene-edited animals showed better body temperature regulation, superior growth characteristics, and in bulls, larger scrotal circumference, an indicator of reproductive fitness.10PubMed Central. Consequences of gene editing of PRLR on thermotolerance growth and male reproduction in cattle Ongoing field trials are also testing whether the slick mutation can help cattle tolerate toxic fescue, a common pasture grass that causes significant weight loss and health problems in conventional herds.11Journal of Animal Science. 107. Gene Editing the Slick Mutation to Mitigate Fescue Toxicosis Losses
Biomedical Applications
Animal biotechnology plays a central role in human medicine, particularly in disease modeling and the long-standing challenge of organ shortage. Genetically modified mice have become indispensable tools for studying human diseases. With modern molecular techniques, researchers can now mimic not only single-gene disorders but also chromosomal conditions, multifactorial diseases, and even infectious diseases in lab animals. These models allow scientists to trace how a disease develops and, critically, to test new therapies before they reach human trials.12PubMed. Genetically modified mice as a tool for the study of human diseases
Mice have obvious limitations, though. Their small size and different physiology mean that many findings do not translate well to humans. Gene editing tools now allow researchers to introduce known human disease mutations into larger animals like pigs and sheep, whose organ size and physiology are closer to ours.13PubMed Central. Engineering large animal models of human disease Pigs in particular have become important for xenotransplantation research, the goal of transplanting animal organs into humans. The main obstacle is that the human immune system violently rejects pig tissue. Most current research focuses on genetically modifying donor pigs to prevent or reduce this immune attack.14PubMed Central. Genetically engineered pigs for xenotransplantation: Hopes and challenges
A key breakthrough involved inactivating the gene responsible for a sugar molecule on pig cell surfaces that triggers the most severe form of rejection. Pigs with this gene knocked out were first produced in the early 2000s. When hearts from these modified pigs were transplanted into immune-suppressed baboons, the longest-surviving graft functioned for 179 days.15PubMed Central. Genetically Modified Pigs as Organ Donors for Xenotransplantation More recent pig-to-human transplant cases have drawn intense media attention, and while significant hurdles remain, the trajectory of the research is toward increasingly successful outcomes.
Faster-Growing Fish and Engineered Insects
Aquaculture has its own long history with animal biotechnology. Transgenic coho salmon carrying an all-salmon growth hormone gene construct grow faster throughout their life, particularly during their freshwater phase, showing precocious development and a compressed life cycle compared to wild-type fish. Different transgenic lines established from separate founder animals showed distinct growth characteristics, suggesting that where the transgene landed in the genome matters. Researchers also found that making transgenic salmon triploid (carrying three sets of chromosomes, rendering them sterile) reduced their growth advantage somewhat but still left them significantly larger than non-transgenic controls, offering a potential containment strategy if these fish were ever released or escaped.16Aquaculture. Growth, viability and genetic characteristics of GH transgenic coho salmon strains
On the insect side, biotechnology is being used to suppress populations of disease-carrying mosquitoes. One approach involves releasing large numbers of lab-reared male mosquitoes infected with a bacterium called Wolbachia, which makes them incompatible with wild females. When these males mate with wild females, the resulting eggs do not develop. A field trial in Fresno, California, involving the release of millions of these mosquitoes achieved a roughly 95% reduction in the target Aedes aegypti population compared with control sites.17PubMed Central. Oxitec and MosquitoMate in the United States: lessons for the future of gene drive mosquito control Similar strategies using genetically sterile insects are being tested or deployed in several countries to combat dengue, Zika, and other mosquito-borne diseases.
Conservation and De-Extinction
The same technologies developed for agriculture and medicine are increasingly being explored as conservation tools. Cloning, gene editing, and advanced reproductive techniques can theoretically help rescue critically endangered species by boosting genetic diversity in shrinking populations, a concept sometimes called “genetic rescue.” More ambitiously, de-extinction projects aim to use these tools to bring back species that have already disappeared, or more precisely to engineer living animals that closely resemble extinct ones and could fill vacant ecological roles.18Journal of Heredity. De-extinction technology and its application to conservation
This area generates real tension in the conservation community. Critics worry that de-extinction projects, particularly those driven by private companies seeking spectacle, could divert resources from protecting species that are still alive and undermine public trust in legitimate conservation uses of cloning. Some policy analysts have recommended that regulatory frameworks prioritize genetic rescue efforts with verified species recovery goals and limit non-conservation-driven projects.19Journal of Science Policy & Governance. Establishing a Regulatory Framework for Cloning in Wild Animal Conservation Whether biotechnology becomes a meaningful conservation tool or a sideshow will likely depend on how those governance questions are resolved.
Tackling Methane from the Rumen
Livestock are a major source of methane, a potent greenhouse gas, and most of that methane comes from microbes in the rumen (the first stomach chamber of cattle and sheep) that produce it as a byproduct of digesting feed. Gene editing is now being explored as a way to attack this problem from two angles at once: modifying forage crops to contain more lipids or secondary plant compounds that naturally suppress methane-producing microbes, and directly editing the genomes of the methane-producing archaea themselves to disrupt their methane-synthesis pathways.20Trends in Biotechnology. CRISPR/Cas-mediated engineering of forage crops and rumen methanogens for methane mitigation This work is still in early stages, but the possibility of genetically reducing enteric methane emissions without fundamentally changing livestock production systems makes it one of the more intriguing environmental applications of the technology.
Cultivated Meat
Cultivated meat, sometimes called lab-grown or cell-cultured meat, takes a different approach entirely. Instead of modifying a living animal, it starts with animal cells, typically stem cells or muscle satellite cells, and grows them in a bioreactor to produce muscle and fat tissue outside the animal’s body. The concept has been studied for over a decade, and while the core tissue-engineering technologies exist, producing something that convincingly mimics the visual appearance, texture, smell, and taste of conventional meat at an affordable price remains a formidable challenge.21PubMed. Cultured meat from stem cells: challenges and prospects
Scaling up is the central bottleneck. Industrial production would require stable cell lines from multiple species, each capable of generating the different cell types, muscle, fat, connective tissue, needed to recreate the complex structure of a steak or a chicken breast.22PubMed Central. Stem cell-based strategies and challenges for production of cultivated meat A handful of companies have received regulatory approval to sell cultivated meat products in specific markets, but widespread commercial availability is still years away. The field sits at the intersection of animal biotechnology, food science, and industrial bioengineering, and its success or failure will shape how we think about the relationship between animals and protein production.
Technical Hurdles That Slow Things Down
For all the promise, precision gene editing in animals is not as clean as it sounds. Two problems in particular keep researchers busy: mosaicism and off-target edits. Mosaicism occurs when the editing tool does its work after the fertilized egg has already begun dividing, so some cells in the resulting embryo carry the edit and others do not. The animal ends up as a patchwork, which complicates both research and breeding. In bovine embryos injected with CRISPR components, mosaicism rates can be extremely high, reaching 94 to 100% depending on whether the editing reagent is delivered as protein or messenger RNA.23PubMed Central. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos
Off-target mutations, where the editing tool cuts DNA at unintended locations, are the other major concern. The good news is that studies using next-generation sequencing to look for off-target cuts have generally found little to no unintended damage when the guide molecules are well designed. One study in porcine embryos, for instance, found no unintended insertions or deletions at the highest concentration of CRISPR components tested, while also achieving lower mosaicism rates at that concentration.24Re:GEN Open. Electroporation of CRISPR/Cas9 Targeting Neurogenin 3 (NGN3) in Porcine Embryos and Its Effects on Mosaicism and Off-Target Effects by Next Generation Sequencing (NGS) Delivery method, timing, and concentration all matter, and optimizing these variables for each species and target gene remains slow, empirical work.
A Patchwork of Regulations
How gene-edited animals are regulated varies enormously depending on where you are. There is no single global approach, and the philosophical differences between jurisdictions are stark. Some countries focus on the process used to create the organism: if gene editing was involved, the product is regulated as a genetically modified organism regardless of the outcome. Others focus on the product: if the resulting animal could have arisen through natural mutation or conventional breeding, it may be exempt from GMO rules.25Frontiers in Genome Editing. Global regulatory policies for animal biotechnology: overview, opportunities and challenges
Argentina, Japan, Australia, and New Zealand have adopted frameworks that exempt certain gene-edited animals, those carrying mutations that could theoretically have occurred naturally, from GMO legislation, though developers still need to demonstrate compliance before receiving an exemption. Argentina has taken this position since 2011. The European Union, by contrast, took a harder line in 2018 when the European Court of Justice ruled that organisms modified through site-directed mutagenesis, including CRISPR edits, must be classified as GMOs regardless of the size or type of alteration.26PubMed Central. Genetically Modified Animal-Derived Products: From Regulations to Applications The United States uses a unique system where oversight is split among multiple agencies depending on the intended use of the animal. This regulatory fragmentation means that a gene-edited pig approved in one country may face years of additional review, or outright prohibition, in another.
What Consumers Actually Think
Public acceptance does not track neatly with scientific consensus, and it shifts depending on what kind of biotechnology is involved and what species it is applied to. Surveys in China found that while consumers were generally wary of biotechnology in food, they were considerably more accepting of gene-edited products than traditionally transgenic ones, likely because gene editing can be framed as a more precise, smaller change.27Food Quality and Preference. Consumer acceptance of gene-edited food products in China Providing information that reduced consumers’ fear of the technology substantially increased their willingness to pay for these products.
In the United States, a study found that consumers distinguish between plant and animal applications: biotech applied to animals tends to generate more resistance than the same techniques applied to crops. This difference tracked with individual risk tolerance. People with lower risk propensity were more bothered by gene-edited animal products specifically, while those with higher risk tolerance did not draw a meaningful distinction between plants and animals.28Journal of Agricultural and Applied Economics. Risk Propensity and Acceptance of Gene-edited and Genetically Modified Food among US Consumers: A Comparison between Plants and Animal Products This pattern suggests that the path to market for gene-edited livestock products may be bumpier than for gene-edited crops, even when the science and safety profiles are comparable.
Who Owns a Gene-Edited Animal
As animal biotechnology moves toward commercialization, intellectual property becomes a serious issue. Patenting transgenic animals and their traits raises tangled legal, ethical, and economic questions. Patent holders can control not just the technology but the resulting animals and their offspring through restrictive licensing agreements, creating barriers to entry for smaller farms and independent breeders. The tension is familiar from the crop-biotech world: strong IP protections encourage private investment in expensive, long-horizon research, but they also concentrate power in a small number of companies and can limit who benefits from the technology.29PubMed Central. Intellectual Property Rights in Animal Biotechnology How this balance is struck, particularly in livestock sectors that rely on open breeding populations, will shape whether gene-editing tools widen or narrow the options available to producers around the world.